Complete remission of original warts
| Population* | Podophyllin % (95% CI) | Podophyllotoxin cream % (95% CI) | Podophyllotoxin solution % (95% CI) |
|---|---|---|---|
| (A) Expressed as % of subjects | |||
| Principal analysis | 53.1 (42.7 to 63.2) | 64.6 (53.3 to 74.9) | 75.0 (65.1 to 83.3) |
| “Worst case” | 44.8 (35.6 to 54.3) | 44.9 (35.7 to 54.3) | 60.0 (50.7 to 68.8) |
| “Best case” | 60.3 (50.8 to 69.3) | 75.4 (66.6 to 82.9) | 80.0 (71.7 to 86.7) |
| Population* | Podophyllotoxin cream Odds (95% CI) | Podophyllotoxin solution Odds (95% CI) | |
|---|---|---|---|
| *See Methods, analysis for definitions of the populations. | |||
| †In regression analyses smoking was not significantly associated with remission, whereas females and having >10 warts at baseline had significantly increased odds of not remitting. | |||
| (B) Expressed as odds of remitting compared to podophyllin (=1) by regression analyses† | |||
| Principal analysis | 1.67 (0.89 to 3.15) | 2.88 (1.52 to 5.45) | |
| “Worst case” | 1.01 (0.59 to 1.96) | 1.96 (1.15 to 3.33) | |
| “Best case” | 2.14 (1.19 to 3.82) | 2.91 (1.59 to 5.34) | |